Imagenebio, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on June 16, 2026, specifically the Company's 2026 Annual Meeting of Stockholders. Imagenebio, Inc. is a Delaware corporation with its principal executive offices in San Diego, California, and its common stock trades on The Nasdaq Capital Market under the symbol IMA.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and equity plan amendments rather than financial performance data.
Material Changes and Corporate Actions
- Equity Plan Amendment: Stockholders approved an amendment to the 2025 Equity Incentive Plan, increasing the authorized share pool by 850,000 shares. The amendment also modifies the annual automatic share reserve increase calculation to include shares issuable upon conversion of preferred stock and exercise of prefunded warrants.
- Director Elections: Stockholders elected David P. Bonita, M.D., and Joseph P. Slattery as Class II directors for terms expiring in 2029.
- Auditor Ratification: Stockholders ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Voting Results and Shareholder Data
As of the record date (April 28, 2026), there were 11,279,130 outstanding shares of voting common stock. Key voting outcomes included:
- Proposal 1 (Directors): Both nominees received over 6.9 million votes "For" with minimal votes withheld.
- Proposal 2 (Auditor): Ratified with 7,613,075 votes "For" versus 20,477 "Against".
- Proposal 3 (Equity Plan): Approved with 6,322,909 votes "For" versus 591,191 "Against".
Outlook, Risks, and Management Commentary
The filing does not contain forward-looking guidance, management commentary on financial outlook, or specific risk factors beyond the standard incorporation by reference to the Proxy Statement for details on the Equity Incentive Plan.
Key Facts for Investor Verification
- Verify the total number of shares authorized under the amended 2025 Equity Incentive Plan to assess potential dilution.
- Review the definitive Proxy Statement filed on April 30, 2026, for the full text of the Amended Plan and detailed terms.
- Confirm the composition of the Board of Directors following the election of the new Class II directors.
- Check subsequent filings for the Company's financial performance for the fiscal year ending December 31, 2026, as this 8-K does not contain financial statements.